2009•Journal watchRequires access

Triamcinolone Acetonide Aqueous Nasal Spray: Safe and Effective in Young Children

Robin Drucker

Open publisher page 0 citations

Abstract

Allergic rhinitis affects up to 42% of children by age 6 years, but few studies have evaluated the effects of intranasal corticosteroids in children aged 2 to 5 years. To address concerns that intranasal corticosteroids may affect the hypothalamic-pituitary axis and growth of young children, researchers conducted a manufacturer-funded, randomized, double-blind, placebo-controlled study of triamcinolone acetonide aqueous nasal spray (TAA AQ) in children aged 2 to 5 years who had allergic rhinitis. Children with symptoms of allergic rhinitis for at least 1 …

About this research paper

What this paper is about

Allergic rhinitis affects up to 42% of children by age 6 years, but few studies have evaluated the effects of intranasal corticosteroids in children aged 2 to 5 years. To address concerns that intranasal corticosteroids may affect the hypothalamic-pituitary axis and growth of young children, researchers conducted a manufacturer-funded, randomized, double-blind, placebo-controlled study of triamcinolone acetonide aqueous nasal spray (TAA AQ) in children aged 2 to 5 years who had allergic rhinitis. Children with symptoms of allergic rhinitis for at least 1 …

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Allergic rhinitis affects up to 42% of children by age 6 years, but few studies have evaluated the effects of intranasal corticosteroids in children aged 2 to 5 years. To address concerns that intranasal corticosteroids may affect the hypothalamic-pituitary axis and growth of young children, researchers conducted a manufacturer-funded, randomized, double-blind, placebo-controlled study of triamcinolone acetonide aqueous nasal spray (TAA AQ) in children aged 2 to 5 years who had allergic rhinitis. Children with symptoms of allergic rhinitis for at least 1 …

Key concepts: Triamcinolone acetonide, Medicine, Nasal spray, Nasal administration, Placebo, Corticosteroid, Anesthesia, Pediatrics

Related papers

Back to paper searchBrowse research topicsOriginal source
Triamcinolone Acetonide Aqueous Nasal Spray: Safe and Effective in Young Children — Research Paper | ScholarLens